Abstract
New research on Artificial Intelligenc e is the subject of a report. According to news reporting originating in Sichuan , People's Republic of China, by NewsRx journalists, research stated, "Cardiac A myloidosis (CA) occurs when misfolded proteins accumulate in the heart muscle, l eading to restrictive cardiomyopathy and possibly escalating to heart failure, i mpaired conduction system function, and sudden cardiac arrest. It is a significa nt clinical challenge due to its high rates of underdiagnosis and misdiagnosis." The news reporters obtained a quote from the research from Sichuan University, " Research indicates that about 35% of individuals with CA have been incorrectly diagnosed with other prevalent cardiovascular diseases. CA is diffe rentiated into various subtypes depending on the protein involved in its pathoge nesis, with Transthyretin Amyloidosis (ATTR) and Light Chain Amyloidosis (AL) be ing the most common. A key diagnostic challenge is the subtle clinical presentat ion of CA, which often resembles other heart conditions such as restrictive card iomyopathy with left ventricular hypertrophy or hypertrophic obstructive cardiom yopathy (HOCM). While several diagnostic methods are available for CA, many are expensive, invasive, and typically used after an initial clinical suspicion. Non -invasive tests like electrocardiography (ECG) are accessible but often have low er sensitivity in detecting CA. Given the limited expertise in recognizing CA sy mptoms in primary care settings, there is an urgent need for systems that can ai d in early detection."
NETL
NSTL